Medicare Enrolled
Dr. Brian Rambarran, MD, MPH
Urology Physician · Sanborn, NY
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rambarran from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rambarran?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rambarran
Dr. Brian Rambarran is an urology physician in Sanborn, NY, with 18 years of NPI registration. Based on federal Medicare data, Dr. Rambarran performed 4,693 Medicare services across 3,135 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rambarran received a total of $6,764 from 31 pharmaceutical and/or device companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rambarran is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 18% volume in NY
$6,764 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,693
Medicare services
Top 18% in NY for urology physician
3,135
Unique beneficiaries
$47
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~261 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
1,456 | $2 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
778 | $86 | $160 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
622 | $59 | $115 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
395 | $8 | $8 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
317 | $8 | $85 |
| PSA test (prostate cancer screening) | 199 | $18 | $41 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
119 | $113 | $254 |
| CT guidance for radiation therapy This procedure uses computed tomography imaging to guide the precise placement of radiation therapy fields. It ensures accurate positioning for targeted treatment delivery. |
109 | $93 | $275 |
| Intensity-modulated radiation therapy delivery Delivery of radiation therapy using narrow beams that are spatially and temporally modulated to target specific areas. This process is performed per treatment session. |
100 | $275 | $820 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 66 | $133 | $650 |
| Telephone medical discussion, 5-10 minutes A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters. |
50 | $41 | $70 |
| Free PSA test A blood test that measures the amount of unbound prostate-specific antigen in the blood. |
45 | $18 | $40 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
44 | $0 | $25 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
37 | $11 | $50 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
34 | $276 | $500 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
34 | $24 | $500 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
32 | $44 | $200 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
29 | $76 | $930 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
26 | $138 | $600 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
25 | $97 | $200 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
21 | $121 | $400 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
21 | $116 | $200 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
20 | $91 | $500 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
19 | $21 | $300 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
19 | $82 | $178 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
18 | $6 | $175 |
| Bladder biopsy using endoscope A procedure to remove a small tissue sample from the bladder using a thin, flexible tube with a camera. The sample is then examined to check for abnormalities. |
17 | $100 | $850 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
15 | $105 | $924 |
| Ureteral stone crushing with stent insertion An endoscope is used to break up a stone in the ureter, followed by the placement of a stent to keep the ureter open. |
14 | $299 | $1,000 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
12 | $548 | $1,810 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
14.1% medium
84.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,764
Total received (2018-2024)
Avg $966/year across 7 years
Top 25% in NY for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
262
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,764 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,103
2023
$813
2022
$761
2021
$802
2020
$220
2019
$739
2018
$2,326
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$572
UROGEN PHARMA, INC.
$101
Sumitomo Pharma America, Inc.
$76
Ferring Pharmaceuticals Inc.
$69
ABBVIE INC.
$62
PROCEPT BioRobotics Corporation
$47
ACCORD HEALTHCARE, INC.
$38
Bayer Healthcare Pharmaceuticals Inc.
$23
Teleflex LLC
$21
Olympus America Inc.
$20
Calyxo, Inc.
$20
Boston Scientific Corporation
$19
Myriad Genetic Laboratories, Inc.
$17
PFIZER INC.
$16
Top 3 companies account for 68.0% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$2,085
Astellas Pharma US Inc
$1,197
Janssen Biotech, Inc.
$1,036
ABBVIE INC.
$259
Sumitomo Pharma America, Inc.
$253
PFIZER INC.
$237
Teleflex LLC
$210
UROVANT SCIENCES INC
$188
TOLMAR Pharmaceuticals, Inc.
$179
BOSTON SCIENTIFIC CORPORATION
$115
Myovant Sciences Inc.
$103
UROGEN PHARMA, INC.
$101
Ferring Pharmaceuticals Inc.
$95
Allergan, Inc.
$94
AbbVie Inc.
$92
AbbVie, Inc.
$70
Avadel Specialty Pharmaceuticals, LLC
$64
ACCORD HEALTHCARE, INC.
$58
PROCEPT BioRobotics Corporation
$47
Olympus America Inc.
$38
Novartis Pharmaceuticals Corporation
$38
Dornier MedTech America, Inc
$32
Boston Scientific Corporation
$32
Bayer Healthcare Pharmaceuticals Inc.
$23
Dendreon Pharmaceuticals LLC
$21
Calyxo, Inc.
$20
Myriad Genetic Laboratories, Inc.
$17
Bayer HealthCare Pharmaceuticals Inc.
$17
Tolmar, Inc.
$15
Endo Pharmaceuticals Inc.
$14
Retrophin, Inc.
$12
Top 3 companies account for 63.8% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · AQUABEAM SYSTEM · Androgel · BOTOX · CAMCEVI · CVAC ASPIRATION SYSTEM · ELIGARD · ERLEADA · Erleada · FIRMAGON · Flexiva · GEMTESA · GENERAL ERECTILE DYSFUNCTION · JELMYTO · LUPRON DEPOT · Lithotripters & Accessories · Lupron · Lupron Depot · MYRBETRIQ · MYRISK · Myrbetriq · NOCDURNA · Noctiva · Nubeqa · ORGOVYX · PLUVICTO · PREMARIN · PROVENGE · TOVIAZ · UROLIFT · UroLift · UroLift System · VESICARE · XIAFLEX · XTANDI · Xofigo · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
42
Per 100K population
19.9
County median income
$67,809
Nearest hospital
MOUNT ST. MARY'S HOSPITAL & HEALTH CENTER
6.0 mi
6.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rambarran is a clinical cardiology specialist, with above-average Medicare volume (top 18% in NY), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rambarran experienced with automated urinalysis?
Based on Medicare claims data, Dr. Rambarran performed 1,456 automated urinalysis services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rambarran receive payments from pharmaceutical companies?
Yes. Dr. Rambarran received a total of $6,764 from 31 companies across 262 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rambarran's costs compare to other urology physicians in Sanborn?
Dr. Rambarran's average Medicare payment per service is $47. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rambarran) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Sanborn
Browse urology physicians in Sanborn ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NY
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NY
Which NY urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology